TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmadule Morimatsu AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
229,644
|
565,095
|
323,911 |
| Financial expenses |
16,829
|
17,510
|
99,438 |
| Earnings before taxes |
6,906
|
20,139
|
11,024 |
| EBITDA |
9,506
|
9,308
|
-9,601 |
| Total assets |
402,859
|
266,110
|
205,534 |
| Current assets |
401,508
|
264,714
|
196,024 |
| Current liabilities |
357,812
|
202,320
|
158,906 |
| Equity capital |
42,832
|
61,499
|
45,378 |
| - share capital |
1,299
|
1,343
|
1,336 |
| Employees (average) |
16
|
14
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
10.6%
|
23.1%
|
22.1% |
| Turnover per employee |
14,353
|
40,364
|
23,136 |
| Profit as a percentage of turnover |
3.0%
|
3.6%
|
3.4% |
| Return on assets (ROA) |
5.9%
|
14.1%
|
53.7% |
| Current ratio |
112.2%
|
130.8%
|
123.4% |
| Return on equity (ROE) |
16.1%
|
32.7%
|
24.3% |
| Change turnover |
-316,759
|
239,515
|
180,323 |
| Change turnover % |
-58%
|
74%
|
126% |
| Chg. No. of employees |
2
|
0
|
0 |
| Chg. No. of employees % |
14%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.